ImmunityBio (IBRX) Profit After Tax (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -921.31% |
| Dec 31, 2025 | 7.87% |
| Sep 30, 2025 | 27.35% |
| Jun 30, 2025 | 28.59% |
| Mar 31, 2025 | -119.37% |
| Dec 31, 2024 | 31.06% |
| Sep 30, 2024 | 36.30% |
| Jun 30, 2024 | -0.34% |
| Mar 31, 2024 | 42.53% |
| Dec 31, 2023 | -144.18% |
| Sep 30, 2023 | 30.84% |
| Jun 30, 2023 | -18.55% |
| Mar 31, 2023 | -8.38% |
| Dec 31, 2022 | 3.23% |
| Sep 30, 2022 | -17.22% |
| Jun 30, 2022 | 7.93% |
| Mar 31, 2022 | -12.50% |
| Dec 31, 2021 | -4.48% |
| Sep 30, 2021 | 1.96% |
| Jun 30, 2021 | -11.06% |
| Mar 31, 2021 | -150.47% |
| Dec 31, 2020 | 51.44% |
| Sep 30, 2020 | -28.64% |
| Jun 30, 2020 | -38.88% |
| Mar 31, 2020 | -136.80% |
| Dec 31, 2019 | -0.39% |
| Sep 30, 2019 | 6.60% |
| Jun 30, 2019 | 6.73% |
| Mar 31, 2019 | -3.14% |
| Dec 31, 2018 | 26.63% |
| Sep 30, 2018 | 14.77% |
| Jun 30, 2018 | -0.77% |
| Mar 31, 2018 | -12.38% |
| Dec 31, 2017 | -2.16% |
| Sep 30, 2017 | -2.20% |
| Jun 30, 2017 | 4.34% |
| Mar 31, 2017 | -1.14% |
| Dec 31, 2016 | 24.01% |
| Sep 30, 2016 | 6.18% |
| Jun 30, 2016 | -10.82% |
| Mar 31, 2016 | -14.37% |
| Dec 31, 2015 | 42.08% |
| Sep 30, 2015 | 64.62% |
| Jun 30, 2015 | -298.47% |
| Mar 31, 2015 | -1,092.34% |
| Dec 31, 2014 | -200.11% |
| Sep 30, 2014 | 35.49% |
| Jun 30, 2014 | -30.67% |